TrialClinical pharmacology in drug development2018

Bioequivalence and Safety of Twice-Daily Sustained-Release Paracetamol (Acetaminophen) Compared With 3- and 4-Times-Daily Paracetamol: A Repeat-Dose, Crossover Pharmacokinetic Study in Healthy Volunteers.

Dongzhou J Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.